Female SUI Research Articles

Transvaginal posterior levatorplasty and perineoplasty for female primary stress urinary incontinence: 12-month follow-up and technical presentation

ObjectiveTo investigate the feasibility of transvaginal posterior levatorplasty combined with perineoplasty (TPLP) for women with primary stress urinary incontinence and demonstrate the surgical technique with step-by-step procedures.MethodsA prospective, non-randomised study was conducted using technique of TPLP to treat female primary SUI from January 2019 to December 2021. Patient follow-up was performed at 3 and 12 months posteroperatively. A series of validated questionnaires were used to evaluate the improvement of symptom severity, sexual function and quality of life. In addition, 4-D ultrasonography was used to measure the anatomic changes of pelvic structures.ResultsA total of 47 patients were enrolled in this study with a mean age of 43.6 years. Mean operative time was 78.7 min. Median estimated intraoperative blood loss was 80.2 ml. Objective cure and subjective cure rates were 87.2% and 91.5%, respectively. Compared with baseline, scores of quality of life, symptom severity and sexual function improved after surgery. Meanwhile, mobility of the urethra and bladder neck and areas of levator hiatus were decreased after surgery. Mild coitus pain was reported in 15.4% (6/39) patients at the initial several times of intercourse after resuming sexual activity.ConclusionsThis study shows that transvaginal posterior levatorplasty combined with perineoplasty appears to be an effective surgical method for selected women with primary stress urinary incontinence.

MP37-19 TOWARDS A COMMON MINIMUM DATA SET FOR THE FEMALE SUI SURGICAL LITERATURE: RECOMMENDATIONS OF THE SUFU SUI PUBLICATION OUTCOMES WORKING GROUP

You have accessJournal of UrologyCME1 Apr 2023MP37-19 TOWARDS A COMMON MINIMUM DATA SET FOR THE FEMALE SUI SURGICAL LITERATURE: RECOMMENDATIONS OF THE SUFU SUI PUBLICATION OUTCOMES WORKING GROUP Eric Rovner, Christopher Chermansky, Roger Dmochowski, Ekene Enemchukwu, David Ginsberg, Geneviève Nadeau, and Phillippe Zimmern Eric RovnerEric Rovner More articles by this author , Christopher ChermanskyChristopher Chermansky More articles by this author , Roger DmochowskiRoger Dmochowski More articles by this author , Ekene EnemchukwuEkene Enemchukwu More articles by this author , David GinsbergDavid Ginsberg More articles by this author , Geneviève NadeauGeneviève Nadeau More articles by this author , and Phillippe ZimmernPhillippe Zimmern More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003275.19AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Relevant, meaningful, and achievable data points are critical in objectively assessing quality, utility and outcomes in female SUI surgery. Adherence to the previously proposed minimum data set for future studies in female SUI surgery, outlined in the first AUA Guidelines on the Surgical Management of Female SUI in 1997, has been suboptimal. The SUFU SUI Publication Outcomes Working Group (SSPOWG) was tasked with creating a common minimum data set to be utilized by authors, investigators, journal editors, and reviewers in refereeing literature pertaining to SUI surgery. METHODS: The SSPOWG reviewed the minimum data set proposed in the 1997 AUA SUI Guideline document, and other relevant literature. The body of literature was examined in the context of the profound changes in the field over the past 25 years. Through an iterative process, a minimum data set was generated balancing the desire to have a number of meaningful and relevant data points against the burden of creating an excessively difficult or restrictive standard that would disincentivize widespread adoption. RESULTS: The minimum data set is sub-divided into 3 categories: 1. study features/design; 2. preoperative evaluation; 3. postoperative evaluation. Important study features include an accounting of all patients entered into the study and defined criteria for success. Preoperative evaluation should include relevant demographic, anatomical, and physiological characterization of the population under study and patient reported data in the form of a standardized questionnaire. Postoperative evaluation should include follow up data for all patients at a minimum of one year, at least one residual urine assessment and physical examination, a thorough accounting of intraoperative and postoperative complications/adverse events, outcomes related to the pre- defined criteria for success/failure, and a postoperative patient reported outcomes assessment measured with standardized questionnaire(s). CONCLUSIONS: A reasonable, achievable, and clinically meaningful minimum data set has been constructed. Such a structured framework will allow future surgical interventions for female SUI to be objectively scrutinized and compared in a clinically significant manner. Ultimately, such a data set, if adopted by the academic community, will improve the quality of the female SUI surgical literature. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e522 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Eric Rovner More articles by this author Christopher Chermansky More articles by this author Roger Dmochowski More articles by this author Ekene Enemchukwu More articles by this author David Ginsberg More articles by this author Geneviève Nadeau More articles by this author Phillippe Zimmern More articles by this author Expand All Advertisement PDF downloadLoading ...

Adherence to the Minimum Data Set Suggested by American Urological Association Guidelines for the Surgical Treatment of Stress Urinary Incontinence

ObjectiveTo assess contemporary adherence to the minimum data set proposed for future publication in the 1997 American Urological Association (AUA) guidelines on the surgical management of female SUI in 1997. guidelines among recently published literature. Materials and MethodsWe reviewed all publications included in the AUA/SUFU Surgical Treatment of Female SUI Guidelines and included articles that reported surgical outcomes for SUI treatment. They were abstracted for the reporting of the previously defined 22 data points. Each article received a compliance score as a percent of parameters met out of the 22 data points. ResultsThree hundred eighty articles from the 2017 AUA guidelines search, in combination with an independent updated literature search were included. There was an average compliance score of 62%. The best compliance rates for individual data points were: defined criteria for success (95%) and patient history (97%). The lowest compliance rates were: minimum follow-up >48 months (8%) and post-treatment micturition diary (17%). There was no difference between mean rates of reporting for articles before and after the SUFU/AUA 2017 guidelines (61% pre vs 65% post). ConclusionAdherence to reporting the most recent minimum standards in the current SUI literature is largely suboptimal. This apparent lack of compliance may suggest a role for a more stringent editorial review process, or alternatively that the prior suggested data set was overly burdensome and/or irrelevant.

Effect of vaginal energy-based treatment on female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials.

To evaluate the efficacy and safety of vaginal energy-based therapies in treating female SUI. The PubMed, EMBASE, Web of Science, and Scopus databases were searched up to September 2022 to identify RCTs comparing energy-based therapies with placebo intervention in treating female SUI. The primary outcome was International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score. Secondary outcomes included the 1-h pad test and cure rate. A total of 577 patients from 6 studies were included in the meta-analysis. Energy-based therapies did not significantly improve the ICIQ-SF score at all visits (≤ 1month: SMD, -0.39; 95% CI -0.80 to 0.03; P = 0.07; 3months: SMD, -1.32; 95% CI -4.07 to 1.43; P = 0.35; 6months: SMD, -0.39; 95% CI -0.91 to 0.12; P = 0.14). The subgroup analysis showed that there was no significant improvement in ICIQ-SF score in the CO2 laser group compared to the placebo group at all visits (≤ 1month: SMD, -0.13; 95% CI -0.59 to 0.34; P = 0.59; 3months: SMD, -1.50; 95% CI -3.91 to 0.92; P = 0.22; 6months: SMD, 0.13; 95% CI -0.47 to 0.72; P = 0.67). Meta-analysis was not performed in Er: YAG laser and radiofrequency therapy due to insufficient trials. Based on the limited clinical evidence, our meta-analysis showed no prior efficacy of energy-based therapy over placebo intervention. However, the results of this meta-analysis should be taken with caution due to the limited amount of available evidence and the heterogeneity among the included studies. CRD42022360471.

The Characteristics and Influencing Factors of Quality of Life in Female Patients with Stress Urinary Incontinence

<i>Objective</i>: To investigate the current status and influencing factors of quality of life in female patients with stress urinary incontinence to provide a basis for making targeted health education in clinic. <i>Methods</i>: A total of 58 female SUI patients hospitalized in our department from July 2020 to February 2021 were selected as subjects for field investigation. The questionnaire was composed of general information and Incontinence quality of life (I-QOL) questionnaire. Multivariate linear regression was used to analyze the influencing factors of quality of life in female patients with stress urinary incontinence. <i>Results</i>: The quality of life score of female patients with stress urinary incontinence was (66.18±6.70). Regression analysis showed that the number of vaginal births, the number of years of illness, the number of abortions, and the living status were the factors affecting the quality of life of female patients with stress urinary incontinence<i>. Conclusions</i>: The quality of life of female patients with stress urinary incontinence is moderately or severely affected. Medical workers should develop targeted health education according to the influencing factors, popularize the knowledge related to SUI, help patients improve the cognition of stress urinary incontinence, and actively cooperate with treatment, so as to improve the quality of life of patients.

Functional urology: Practice patterns and training aspirations among urologists in Brazil.

Urology has rapidly evolved during the last decades, incorporating new technologies faster than most specialties. The challenge to maintain a competent workforce that is prepared to deliver proper contemporary treatment has become increasingly difficult and newly graduated urologists throughout the world typically lack the skills to practice many urological subspecialties. We performed a survey to evaluate the practice patterns and educational aspirations in functional urology (FU) among Brazilian urologists. A web-based survey was sent to board-certified Brazilian urologists to collect data on clinical practice and training aspirations in four subareas of FU: female urology, urodynamics, postprostatectomy incontinence (PPI), and neurourology. We evaluated urologists' clinical and surgical workload in each subarea and investigated educational training aspirations to identify areas and training formats of interest. A total of 366 urologists (mean age 47.7 + 10.7 years) completed the survey. Mean time since completion of residency was 17.9 + 11.9 years. Of the respondents, 176 (53%) perform urodynamics, 285 (83.1%) SUI surgeries, 159 (47.6%) PPI surgeries, 194 (58.1%) third line OAB procedures, 168 (48.9%) pelvic organ prolapse (POP), and 88 (26.3%) bladder augmentation. Mid-urethral sling is the most performed SUI surgery and transobturator is the preferred route (64.0%). For those performing POP surgery, 40.5% use mesh in at least 50% of their cases, and the vaginal route is used in most cases (75.4%) for apical prolapse. For PPI, 64.6% use artificial sphincter in most surgeries and only 8.1% perform at least 5 surgeries/year. Being fellowship-trained and working in an academic hospital are associated with a higher chance of being active in FU. Most urologists are interested in receiving training in PPI, female SUI, and POP and a hands-on course is the preferred educational method (81%). Most urologists in Brazil are involved in the evaluation and treatment of FU patients, but few have a large volume of patient visits and surgical procedures. Completing a fellowship program and working in an academic practice are associated with a higher chance of being a FU practitioner. There is a high interest in training for PPI, female SUI, and POP.

Autologous fascia pubovaginal slings in women with stress urinary incontinence at high risk of mesh/device-related complications

Very popular in many parts of the world, autologous fascial pubovaginal sling (AFPVS) remains marginally used in France. However, it may be of particular interest in patients carrying a high risk of mesh-related or device-related related complications. The aim of the present series was to report the outcomes of AFPVS in this high-risk population. The charts of all female patients who underwent a fascial sling for SUI at a single academic center between April 2019 and May 2021 were reviewed retrospectively. Only patients deemed at high-risk of device/mesh related complications were included in the present analysis: female with a neurological condition who were doing clean intermittent catheterization (CIC), female with SUI after radical cystectomy and ileal neobladder, female with urethral/bladder extrusion of any synthetic material placed for SUI. Success was defined as complete resolution of SUI at 3 months. Sixteen patients were included in this study: 13 rectus fascia slings and 3 fascia lata slings. The success rate was 56.3% (9/16 patients). Four patients were improved but not completely dry (25%). Two patients had major postoperative complications (i.e. Clavien grade 3 or higher, 11.2%). Two patients had a persisting significant post-void residual (PVR) postoperatively, managed by self-catheterization (transition to self-catheterization at 3 months: 2/8, 25%). The use of autologous fascia pubovaginal sling is an interesting option in female SUI patients with high risk of device/mesh related complications with satisfactory functional outcomes. 4.

Robotic-assisted laparoscopic colposuspension for female stress urinary incontinence: a prospective series.

The suspension of use of sub-urethral mesh in the UK in 2018 has seen the resurgence of colposuspension in female SUI surgery. Open and laparoscopic colposuspension techniques are well recognised. We present data from 28 robotic-assisted laparoscopic colposuspension (RALCp) procedures, reporting on technique, safety and efficacy. Approval was obtained from the hospital New and Novel Procedures Committee. All patients had urodynamic assessment prior to surgery. Data was prospectively gathered and 24-h pad usage and Urinary Incontinence Short Form Questionnaire (ICIQ-UI-SF) scores were used to assess symptom severity and quality of life. PGII scores were used to assess patient satisfaction after the procedure. Paired T test analysis was conducted. Since May 2019, robotic colposuspension has been performed in 28 patients. The mean age and BMI were 49 and 27 (kg/m2), respectively, with a mean follow-up period of 12months. 67.9% of patients had pure urodynamic SUI and 32.1% of patients had previous anti-SUI surgery. Average operating time was 127min, blood loss 20ml and length of stay 2days. There was a significant 73% improvement in mean 24-h pad usage (p = 0.001) and an improvement in mean ICIQ-UI-SF scores from 18.1 to 9.4 (p = 0.0001). Day 1 mean pain score was 5/10. This is the largest series of its kind. Robotic colposuspension is safe and feasible with significant improvements seen in quality of life scores and number of pads used per day. It presents a minimally invasive treatment option in female SUI, however needs larger volume evaluation and longer follow-up for further evaluation.

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD

Registry for Patients Undergoing AUS Surgery for Female SUI Due to ISD

TVT-O vs. TVT-Abbrevo for stress urinary incontinence treatment in women: a randomized trial.

To compare the efficacy, safety and complications of the trans-obturator midurethral sling from inside to outside (TVT-O) and of the shorter trans-obturator midurethral sling (TVT-Abbrevo) for treatment of female SUI. One hundred fifty-eight recruited patients were randomized into either the TVT-O or TVT-Abbrevo group. Preoperative assessment included history and general assessment, urinalysis and urine culture, urogynaecological clinical examination, urodynamic evaluation and urogynaecologic interview by ICIQ-SF-UI, PGI-I and PISQ12. Operative time, perioperative complications, spontaneous voiding, postoperative complications and hospital stay were prospectively recorded in all patients. At 3, 6, 12, 24 and 36months after surgery, patients were asked to answer urogynaecological interviews by ICIQ-SF-UI, PGI-I and PISQ12. The urodynamic assessment was performed at 12, 24 and 36 months. Success rate was assessed at 12, 24 and 36 months postoperatively. Overall, 138 of 158 patients (87%) were cured of SUI 36months after the operation with no significant differences between groups [69 (87%) and 69 (87%) patients in the TVT-O and TVT Abbrevo groups, respectively]. The two groups did not significantly differ in operative time, intraoperative blood loss and length of hospital stay. Nine patients (11%) had postoperative groin pain in the TVT-O group and one patient in the TVT Abbrevo group (p = 0.02). Three-year control demonstrated an equal objective cure rate in both groups. There was a significant improvement in total PISQ-12 and ICIQ-SF-UI scores in both groups at 36months FU. TVT-Abbrevo has similar efficacy and safety compared with TVT-O in women with SUI; the use of a shorter sling reduces postoperative pain.

Urethral Bulking and Salvage Techniques for Post-Prostatectomy Incontinence

Despite limited evidence and efficacy, urethral bulking remains a common treatment for post-prostatectomy stress urinary incontinence (PP-SUI). Herein we provide an overview of the existing evidence for synthetic bulking agents and emerging evidence for stem cell-based sphincter rejuvenation in this setting. We also touch upon salvage techniques for management of PP-SUI after failed anti-incontinence interventions. Autologous stem cell (ASC) therapies are currently undergoing phase III trials for use in female SUI and are poised to enter the market within the next decade. Early data suggests that they may have a future role in PP-SUI management as well. The artificial urinary sphincter (AUS) has emerged as the standard of care for salvage PP-SUI treatment. Treatment paradigms for PP-SUI continue to evolve. Synthetic bulking remains common while autologous bulking looms as a potential future therapy. The AUS remains the last line of defense.

Relationship between hysterectomy and severity of female stress urinary incontinence.

BackgroundStress Urinary Incontinence (SUI) is one of the most reported health dilemmas of women suffering from lower urinary tract symptoms.AimTo determine the relation between hysterectomy and severity of female SUI using Valsalva Leak Point Pressure (VLPP).MethodsThis case-control study was conducted at a public urology clinic in Tehran in 2015. The study population was all female with SUI complaints who visited the clinic during 2015. We compared Valsalva leak point pressure in two groups of female SUI patients with and without hysterectomy history. The inclusion criteria were: not taking any alpha-blocker or anti-cholinergic medicines two weeks prior to the urodynamic test as well as no history of pelvic surgery or cesarean delivery in their lifetime. All qualified patients were invited to participate in the study randomly, and among them, 120 qualified patients agreed to participate by filling out the informed consent form. Data was gathered through direct interview, and double checked by patients’ medical records. All the study variables including age, BMI, delivery number, hysterectomy and UTI history were entered and analyzed by estimating ordered logistic regression and by using Stata14.1 software.ResultsThe mean of VLPP was 70.17 cmH2O in the group with hysterectomy history, and 94.55 cmH2O in those without hysterectomy history. The difference of VLPP pressure between the two studied groups were significant (p<0.05), even after control of confounding variables. Also, the odds of severe SUI among hysterectomy group patients was 6.3 times more than no hysterectomy (OR=6.32, p<0.001).ConclusionsOur study confirms significant relation between hysterectomy and SUI severity measured by Valsalva leak point pressure. Hysterectomy patients are more likely to suffer from more severe grades of SUI.

Female Stress Urinary Incontinence Treatment by Forming an Uretro-Vesical Angle with or without Mesh

Objective: To evaluate, in a comprehensive way, mesh and mesh free SUI treatment results obtained in a single center. The present study addresses the efficacy and safety of a novel surgical technique. Material & Methods: Adult female SUI patients, 184 in total, were divided within a sequential manner into two groups to be treated for SUI either with or without mesh insertion during a surgical intervention. In this novel procedure, a vertical vaginal incision from the urethra towards the bladder bottom is made and closed transversely. After the intervention the patients revisited the clinic at the 6th month. Results: 81 patients in mesh and 83 in the mesh free group completed the 2-year follow up. Based on the pad tests conducted at the end of 24-month follow up, 82% of the patients in the mesh free group and 85% in the mesh group were considered as successful if the pad test resulted with ≤2 gram. Cystocele of Grade I or II was also treated in 69 patients within the same single surgical procedure. Conclusion: The surgical outcomes of the mesh and mesh-free group were almost the same. However, though the cure rate of the mesh group was higher, it was not statistically significant. Adverse events were more frequent in the mesh group due to mesh presence.

MP65-09 ANALYSIS OF UTI RESOLUTION AND SEDIMENT FORMATION ON INTRAVESICAL BALLOON FOR THE TREATMENT OF SUI FROM TWO MULTICENTER RANDOMIZED CONTROLLED STUDIES

INTRODUCTION AND OBJECTIVES: This abstract describes 12 month results for patients that enrolled in the SOLECT Trial, which evaluated the efficacy, safety, and tolerability of the Vesair pressureattenuation balloon for the treatment of female SUI. The study met its primary endpoint at 3 months. Patients in the study had the option to continue therapy beyond the 3 month endpoint for up to 3 years. METHODS: This abstract reports on 22 patients that were evaluated at 12 months. Endpoints included a provocative pad weight test, an Incontinence Quality of Life Survey (I-QOL), incontinence episode frequency, a PGI-I assessment. A composite endpoint was also evaluated, which required both a 1⁄450% decrease in provocative pad weight a 1⁄410 point increase in the 22-item I-QOL to reach success. The deflated balloon is pre-inserted inside the tip of a 19 French (F) delivery system and inserted into the bladder through a sheath, inflated and released. The balloon is removed under direct visualization every 12 months (or earlier if needed) using a custom optical grasper through a sheath. RESULTS: At 12 months, 85% (17/20) had a greater than 50% reduction in pad weight test from baseline (ITT 1⁄477%, 17/22). 75% (15/ 20) leaked less than 2 grams on the pad weight test (ITT1⁄468%(15/22). 72.7% (16/22) of the patients had a greater than 10-point increase on their I-QOL score. 62.8% improved on the PGII assessment, and 68.4% (13/19) had greater than 50% reduction in leaks on a 7-day voiding diary (ITT1⁄459%, 13/22). In an ITT analysis, 69.2% of women in an ITT analysis achieved the composite endpoint. CONCLUSIONS: Results from the trial continue to demonstrate the durability of the balloon in clinically relevant objective and subjective measures of SUI. The pressure attenuation system was safe and caused no urinary retention during the follow-up period. Additional follow-up is warranted to assess the longer-term durability of this therapy.

Regenerative medicine- techniques and methods of administering autologous derived stem cells in urinary incontinence.

The aim of the work is to present regenerative medicine achievement as an alternative SUI treatment and the variety of injected cells type as well as injection techniques itself with the analysis of their quality and possible the mechanism in which they reduce urinary incontinence symptoms. For over a decade numerous authors declare use of different type of autologous mesenchymal-derived stem cells (AMDC) in male and female SUI. The leakage improvement reached 80%, despite the number of injected cells as well as the injection technique. Important subject in the AMDC treatment is the precise cell material injection into the selected spot which might be possible with the use of the endoscopic assisting robot. The robotic supported system for cells procedure might bring the missing percentage in reaching the goal in SUI treatment.

Adjustable vs. ordinary transobturator tape for female stress incontinence. Is there a difference?

ObjectivesTo determine whether there are any significant differences in complications and success rate between adjustable transobturator tape (TOA) and ordinary transobturator tape (TOT) in the treatment of female stress urinary incontinence (fSUI), as the TOA was recently introduced for the treatment of female SUI, its advantage being the ability to adjust the tape after surgery to address over- or under-correction. Patients and methodsIn all, 96 women with SUI (mean age 53years, SD 10) were included in the study. Patients were randomised into two equal groups (group 1, TOA, vs. group 2, TOT). The operative duration, blood loss, intra- and post-operative complications, and the success rate, were compared between the groups. ResultsThere was no statistically significant difference between the groups in cure rates (83% vs. 80%, groups 1 and 2, respectively) or in postoperative stay. The mean operative duration in group 2 was significantly shorter than in group 1. No intraoperative bleeding requiring a blood transfusion was recorded, and there were no bladder injuries. Postoperative adjustment of the tape was only required in three patients in group 1. ConclusionsThe TOA is a safe and accurate method for treating fSUI, but with experienced surgeons there was no difference in the cure rate and postoperative outcome between TOA and TOT.

Does a patient satisfaction questionnaire improve quality of care received in local continence clinics? An audit of patient satisfaction in a district general hospital

Does a patient satisfaction questionnaire improve quality of care received in local continence clinics? An audit of patient satisfaction in a district general hospital

Editorial Comment

The study titled “Radiation History Affects Continence Outcomes After AdVance Transobturator Sling Placement in Patients With Postprostatectomy Incontinence” found a significantly lower success rate for the retrourethral transobturator sling (RTS) implanted in men with postprostatectomy stress urinary incontinence (male SUI) after adjuvant radiotherapy (RT) compared with those who did not undergo adjuvant RT. Although it would be easy to criticize this study because of the small sample size, retrospective nature, and single-institution participation, this study represents the typical type of clinical research that can be done at this time for male SUI, especially given its lower prevalence compared with that of female SUI.

The effect of different frequencies of pudendal nerve electrical stimulation on female stress urinary incontinence

Objective To investigate the effect of different frequencies of pudendal electrical nerve stimulation on female stress urinary incontinence.Methods 60 SUI female patients from Shanghai Research Institute of Acupuncture and Meridian affiliated Yue Yang Hospital were enrolled in a three-times-per-week treatment group (30 paients) and a twice-per-week treatment group (30 patients).Both groups were treated by pudendal nerve electrical stimulation for twelve times.The change of therapeutic effect,symptoms index were observed in both groups before and after the treatment.Results ① Comparison of clinical efficacy:The therapeutic rate of three-times-per-week treatment group was 63.3％ (19/30),the total effective rate was 90.0％ (27/30); the therapeutic rate of twice-per-week treatment group was 36.7％ (11/30),the total effective rate was 76.7％ (23/30).The therapeutic rate showed significant differences between the two groups (x2=4.267,P＜ 0.05); The total effective rate showed no differences between the two groups (x2 =l.920,P＞0.05).② Comparison of clinical symptom score and life quality score:the post-treatment clinical symptom scores of the both groups improved significantly compared with the pre-treatment (tthee-times-prt-week=7.972,ttwice-per-week=9.520,both P＜0.01).Clinical symptom score of three-times-per-week treatment group improved better than twice-per-week treatment group (P＜0.01).Conclusion Three-times-per-week of pudendal nerve electrical stimulation has a better effect on treating female SUI patients. Key words: Stress urinary incontinence; Pudendal nerve electrical stimulation; Treatment frequencies; Clinical therapeutic effect